Blog
Get the latest news about liver diseases and more
Get the latest news about liver diseases and more
Elafibranor is a newly approved treatment for patients with primary biliary cholangitis (PBC) who do not respond adequately to ursodeoxycholic acid. Clinical studies show improved liver function and establish it as a promising therapeutic option.
A study published in The New England Journal of Medicine shows that Bepirovirsen significantly increases the likelihood of achieving a functional cure for chronic hepatitis B.
Fatty liver and hepatitis B can coexist and worsen liver damage. Combined treatment helps reduce inflammation, fibrosis, and disease progression.
A study suggests GST-HG141 may become an effective new hepatitis B treatment for patients with incomplete response to current antiviral therapies.
Metabolic syndrome increases the risk of bile duct cancer, especially in patients with fatty liver, where liver disease tends to be more aggressive.
A study shows spironolactone reduces fatty liver risk in patients with hypertension, lowering liver fat accumulation and slowing fibrosis progression.
Autoimmune hepatitis incidence has increased notably in older adults, with higher prevalence and better treatment response, often presenting with milder symptoms.
A study shows that eating fewer than three times a day and fasting over 14 hours increases fatty liver risk due to circadian rhythm disruption.
15 de November de 2018
30 de June de 2021
30 de January de 2023
It is a chronic progressive liver disease that mainly affects women (90% of cases) from the fourth decade of life.
Up to 30% of patients with cryptogenic hepatitis can be caused by the seronegative hidden infection by hepatitis C virus (HIC).
It is a viral infection of the liver that causes inflammation of the liver and the death of hepatocytes.
Hepatitis is an inflammation of the liver, and in the case of hepatitis C, caused by infection with hepatitis C virus (HCV)
Hepatitis A is an acute inflammatory disease of the liver, caused by infection with hepatitis A virus (VAH).
It is a liver disease of an inflammatory nature and can develop chronically.